Bradley Foster & Sargent Inc Axogen, Inc. Transaction History
Bradley Foster & Sargent Inc
- $5.77 Billion
- Q4 2024
A detailed history of Bradley Foster & Sargent Inc transactions in Axogen, Inc. stock. As of the latest transaction made, Bradley Foster & Sargent Inc holds 84,153 shares of AXGN stock, worth $1.47 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
84,153
Previous 81,164
3.68%
Holding current value
$1.47 Million
Previous $1.14 Million
21.9%
% of portfolio
0.02%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding AXGN
# of Institutions
179Shares Held
36.2MCall Options Held
82.6KPut Options Held
1.1K-
First Light Asset Management, LLC Edina, MN4.51MShares$78.6 Million7.26% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$56.7 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.96MShares$51.6 Million3.39% of portfolio
-
Morgan Stanley New York, NY2.43MShares$42.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$42.3 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $738M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...